← back to search

David A. Bull

University of Bristol · GB
Area of research
Molecular Biology · Surgery
Research interest
Research interests include RNA Interference and Gene Delivery, Transplantation: Methods and Outcomes, Mechanical Circulatory Support Devices, and Electrospun Nanofibers in Biomedical Applications.
h-index
45
citations
10,629
works
215
NIH funding
primary concept
email

Recent publications

The Potential of Topoisomerase Inhibitor-Based Antibody–Drug Conjugates
Pharmaceutics 2022cited by 46position: middledoi
Targeted delivery of heat shock protein 90 inhibitors prevents growth of HER2-positive tumor
Biomaterials 2021cited by 19position: middledoi
Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease
BMC Pulmonary Medicine 2021cited by 17position: middledoi
AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo
Journal of Biological Engineering 2021cited by 10position: middledoi
The Role of Adjuvant Therapy in Advanced Thymic Carcinoma: A National Cancer Database Analysis
The Annals of Thoracic Surgery 2019cited by 25position: middledoi
Cell surface engineering and application in cell delivery to heart diseases
Journal of Biological Engineering 2018cited by 51position: middledoi
Local Anesthetic Systemic Toxicity Induced Cardiac Arrest After Topicalization for Transesophageal Echocardiography and Subsequent Treatment With Extracorporeal Cardiopulmonary Resuscitation
Journal of Cardiothoracic and Vascular Anesthesia 2018cited by 31position: middledoi
One‐Step Method for Instant Generation of Advanced Allogeneic NK Cells
Advanced Science 2018cited by 17position: middledoi
Evaluation of autologous platelet rich plasma for cardiac surgery: outcome analysis of 2000 patients
Journal of Cardiothoracic Surgery 2016cited by 98position: lastdoi
Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction
Circulation 2015cited by 658position: middledoi
Clinical utility of a next generation sequencing panel assay for Marfan and Marfan‐like syndromes featuring aortopathy
American Journal of Medical Genetics Part A 2015cited by 67position: middledoi
Nano‐Self‐Assembly of Nucleic Acids Capable of Transfection without a Gene Carrier
Advanced Functional Materials 2015cited by 54position: lastdoi
Cell surface engineering to enhance mesenchymal stem cell migration toward an SDF-1 gradient
Biomaterials 2014cited by 160position: lastdoi
Safety and Efficacy of Ixmyelocel-T
Circulation Research 2014cited by 70position: middledoi
Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction
JAMA 2013cited by 495position: middledoi
Metabolically Active Human Brown Adipose Tissue Derived Stem Cells
Stem Cells 2013cited by 73position: middledoi
Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia
Biomaterials 2013cited by 37position: middledoi
Synergistically Combined Gene Delivery for Enhanced VEGF Secretion and Antiapoptosis
Molecular Pharmaceutics 2013cited by 18position: middledoi
Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome
New England Journal of Medicine 2012cited by 974position: middledoi
Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Rationale and Design of CARRESS-HF, for the Heart Failure Clinical Research Network
Journal of Cardiac Failure 2012cited by 113position: middledoi
Dendrimer type bio-reducible polymer for efficient gene delivery
Journal of Controlled Release 2012cited by 76position: lastdoi
Targeted Gene Delivery to Ischemic Myocardium by Homing Peptide-Guided Polymeric Carrier
Molecular Pharmaceutics 2012cited by 61position: middledoi
Mesenchymal Stem Cell Population Isolated from the Subepithelial Layer of Umbilical Cord Tissue
Cell Transplantation 2012cited by 60position: lastdoi
Cell Targeting Peptide Conjugation to siRNA Polyplexes for Effective Gene Silencing in Cardiomyocytes
Molecular Pharmaceutics 2012cited by 26position: lastdoi
Post-translational regulated and hypoxia-responsible VEGF plasmid for efficient secretion
Journal of Controlled Release 2012cited by 22position: middledoi
Hypoxia-inducible plasmid expressing both miSHP-1 and HO-1 for the treatment of ischemic disease
Journal of Controlled Release 2012cited by 15position: middledoi
In Situ Electrostimulation Drives a Regenerative Shift in the Zone of Infarcted Myocardium
Cell Transplantation 2012cited by 9position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Young‐Wook Won · University of Arizona8 papers (2012–2018)Kwang Suk Lim · Kangwon National University4 papers (2015–2022)Young‐Wook Won · University of North Texas4 papers (2018–2022)Martin M. LeWinter · University of Vermont Medical Center3 papers (2012–2015)Minjin Jung · University of Arizona3 papers (2018–2021)Margaret M. Redfield · Mayo Clinic3 papers (2012–2015) · 3 papers (2012–2013)Amit Patel · University of Utah3 papers (2012–2016)Minhyung Lee · Hanyang University3 papers (2012–2013)Hyun‐Ah Kim · Ulsan College3 papers (2012–2013)Kihoon Nam · University of Missouri3 papers (2012–2013)Daniel Y. Lee · University of Kentucky3 papers (2015–2021)Amit N. Patel · University of Utah3 papers (2013–2014)Christopher M. O’Connor · Inova Health System2 papers (2012–2012)Jean L. Rouleau · Universal College2 papers (2012–2012)Vanessa Vargas · Universidade Estadual do Norte do Paraná2 papers (2012–2013)G. Michael Felker · Duke University2 papers (2012–2012)Bradley A. Bart · University of Minnesota2 papers (2012–2012)Gabriel M. Valencia · University of Utah2 papers (2015–2018)Anita Deswal · The University of Texas MD Anderson Cancer Center2 papers (2012–2012)